L. Nicolas Gonzalez Castro, Md, Phd

This study is testing a combination of three drugs—pembrolizumab, olaparib, and temozolomide—to see if they can help control recurrent glioblastoma, an aggressive brain tumor that has returned after initial treatment. The trial will enroll about 78 adults whose cancer has come ba…